| |
| |
|
| Insider
Information: |
Gelone Steven P. |
| Relationship: |
Director |
| City: |
King Of Prussia |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
14,283 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,625 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
14,283 |
|
|
| Total
Value |
$5,625 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nabriva Therapeutics AG |
NBRV |
Director |
2023-01-29 |
14,283 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBRV |
Nabriva Therapeutics AG |
Director |
– • – |
2023-01-29 |
4 |
D |
$1.50 |
$210 |
D/D |
(140) |
14,283 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2023-01-06 |
4 |
D |
$1.30 |
$7 |
D/D |
(5) |
14,423 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-12-31 |
4 |
D |
$1.89 |
$6 |
D/D |
(3) |
14,428 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-12-06 |
4 |
D |
$2.02 |
$8 |
D/D |
(4) |
14,431 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-11-30 |
4 |
D |
$2.25 |
$7 |
D/D |
(3) |
14,435 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-11-06 |
4 |
D |
$2.24 |
$9 |
D/D |
(4) |
14,438 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-10-31 |
4 |
D |
$2.54 |
$8 |
D/D |
(3) |
14,442 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-10-06 |
4 |
D |
$2.72 |
$11 |
D/D |
(4) |
14,445 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-09-30 |
4 |
D |
$2.08 |
$6 |
D/D |
(3) |
14,449 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-09-06 |
4 |
D |
$0.16 |
$14 |
D/D |
(89) |
361,311 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-08-31 |
4 |
D |
$0.16 |
$10 |
D/D |
(61) |
361,400 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-08-06 |
4 |
D |
$0.18 |
$16 |
D/D |
(89) |
361,461 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-07-31 |
4 |
D |
$0.18 |
$11 |
D/D |
(61) |
361,550 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-07-06 |
4 |
D |
$0.18 |
$16 |
D/D |
(89) |
361,611 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-06-30 |
4 |
D |
$0.18 |
$11 |
D/D |
(61) |
361,700 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-06-06 |
4 |
D |
$0.20 |
$18 |
D/D |
(89) |
361,761 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-05-31 |
4 |
D |
$0.21 |
$13 |
D/D |
(61) |
361,850 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-05-06 |
4 |
D |
$0.26 |
$23 |
D/D |
(89) |
361,911 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-04-30 |
4 |
D |
$0.31 |
$19 |
D/D |
(61) |
362,000 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-04-06 |
4 |
D |
$0.41 |
$36 |
D/D |
(89) |
362,061 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-03-31 |
4 |
D |
$0.42 |
$26 |
D/D |
(61) |
362,150 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-03-06 |
4 |
D |
$0.43 |
$38 |
D/D |
(89) |
362,211 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-02-28 |
4 |
D |
$0.45 |
$27 |
D/D |
(61) |
362,300 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-02-06 |
4 |
D |
$0.48 |
$51 |
D/D |
(106) |
362,361 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
President and COO |
• • – |
2022-01-31 |
4 |
D |
$0.48 |
$35 |
D/D |
(73) |
362,467 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
